The Effect of Heart Disease, Diabetes, and Hypertention in COVID 19 Patients

Abstract

Background Patients with preexisting diabetes and cardiovascular metabolic illnesses who have coronavirus disease-2019 (COVID-19) have a higher mortality risk. More research is needed to correctly concentrate the influence of previous health issues on COVID-19 results due to the spread of novel variants with evolving clinical features. Aim The primary goal of this study was to look at the effects of diabetes and cardiovascular disease (CVD) on disease prognosis and severe health consequences in individuals with COVID-19. Methods A retrospective analysis was conducted at Damascus hospital on 202 patients with COVID-19 from February 10, 2022, to May 10, 2022. The chi-square test was used to explore the relationship between sickness results and research parameters. The statistical significance level was chosen at P 0.05. Results Men made up 51% of the patients, while women made up 49%. The average age of the patients was 66.5 years. Cough (20%) was the most prevalent clinical complaint among 202 COVID-19 patients, followed by weariness and dyspnea (18%) and fever (17%). 28% of these patients had diabetes, 45% had hypertension, and 16% had heart failure or myocardial infarction. Multiple organ failure occurred in 7% of patients, and patient mortality occurred in 49% of instances. We identified a statistically significant association between the existence of cardiac disease in the patient and the development of problems as a result of COVID-19 infection, with 69% of patients developing difficulties during their infection compared to 64% who did not develop any symptoms. Conclusion In this study, 82 COVID-19 patients passed away. Diabetes, CVD, and COVID-19 patients had the greatest mortality rates. Diabetes and CVD patients were at a much higher risk.